Recent novelties in research and management of cerebrospinal cavernous malformations
2024

Recent Advances in Cerebrospinal Cavernous Malformations

Sample size: 123 publication Evidence: moderate

Author Information

Author(s): Laurel Rauschenbach, Philipp Dammann, Ulrich Sure

Primary Institution: University Hospital Essen, Essen, Germany

Hypothesis

An up-to-date review of the latest developments and controversies in the management of cerebrospinal cavernous malformations is necessary due to the rarity and heterogeneity of the disease.

Conclusion

Surgical resection remains the primary treatment for symptomatic or high-risk cerebrospinal cavernous malformations, with advances in techniques improving outcomes.

Supporting Evidence

  • Knowledge about cerebrospinal cavernomas has grown considerably in recent years.
  • Current guidelines recommend genetic testing in patients with multiple CMs when there is no associated DVA.
  • Surgical resection is the gold standard for symptomatic or high-risk CMs.

Takeaway

Cavernous malformations in the brain can cause serious problems, but doctors are learning more about how to treat them safely and effectively.

Methodology

This narrative review synthesizes current strategies and treatment indications for CNS-CMs based on long-term clinical experience and recent literature.

Potential Biases

The review is based on observational studies, which may be limited by selection bias and short follow-up periods.

Limitations

The level of evidence remains limited due to the rarity and heterogeneity of the disease, and many questions are still unanswered.

Participant Demographics

The study includes a diverse group of patients with cerebrospinal cavernous malformations, but specific demographic details are not provided.

Digital Object Identifier (DOI)

10.1007/s00701-024-06378-3

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication